Literature DB >> 9385938

P53 gene product and EGF-receptor are highly expressed in placental site trophoblastic tumor.

J Müller-Höcker1, N Obernitz, A Johannes, U Löhrs.   

Abstract

Immunohistochemical analysis of curettage material from a placental site trophoblastic tumor (PSTT) revealed a high expression of p53 gene products, of epidermal growth factor receptor (EGF-R) and of Ki-67 (MIB-1) proliferation associated antigen. bcl-2 was not expressed. These results show that in PSTT inactivation/dysregulation of p53 and upregulation of EGF-R and MiB-1 occurs, indicating that these factors are probably involved in tumor genesis and propagation of PSTT. The prognostic significance of the molecular genetic data, however, remains to be established.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385938     DOI: 10.1016/s0046-8177(97)90206-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

Review 1.  Placental site trophoblastic tumor.

Authors:  Nadereh Behtash; Mojgan Karimi Zarchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-16       Impact factor: 4.553

Review 2.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

3.  MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

Authors:  Ronald Tk Pang; Carmen On Leung; Cheuk-Lun Lee; Kevin Kw Lam; Tian-Min Ye; Philip Cn Chiu; William Sb Yeung
Journal:  BMC Cancer       Date:  2013-01-18       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.